Article Information
History
- September 23, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Shaoming Sang, Ph.D.1,†,
- Xiangteng Zhao, Ph.D.1,†,
- Ting Qian, M.D., Ph.D.1,†,
- Yingfeng Xia, M.D., Ph.D.1,†,
- Xiaoli Pan, M.D., Ph.D.1,†,
- Qianhua Zhao, M.D., Ph.D.2,†,
- Fang Cai, Ph.D.3,†,
- Yeting Zeng, M.D.1,
- Wenwen Cai, M.D.1,
- Boru Jin, M.D., Ph.D.1,
- Hongyan Qiu, M.D., Ph.D.1,
- Yangqi Xu, M.D., Ph.D.1,
- Qiang Huang, M.D.1,
- Yun Zhang, Ph.D.3,10,
- Shajin Huang, MS.4,
- Donglang Jiang, M.D., Ph.D.5,
- Yun Wu, Ph.D.6,
- Haiyang Tong, Ph.D.6,
- Qing Zhang, Ph.D.3,7,
- Changpeng Wang, M.D., Ph.D.1,
- Xiaoqin Cheng, M.D., Ph.D.1,
- Kai Zhong6,
- Yihui Guan5,
- Michael X. Zhu, Ph.D.8,
- Xiang Yu, Ph.D.9,
- Peng Yuan, Ph.D.10,
- Weihong Song, M.D., Ph.D.3,7,11,*,
- Chunjiu Zhong, M.D., Ph.D.1,*,
- Benfotiamine Phase 2 Clinical Trial Investigators$
- 1Department of Neurology, Zhongshan Hospital; State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science; Institutes of Brain Science; National Clinical Research Center for Aging and Medicine, Huashan Hospital; Fudan University, Shanghai 200032, China
- 2Department of Neurology, Huashan Hospital, Fudan University, Shanghai 200040, China
- 3Townsend Family Laboratories, Department of Psychiatry, The University of British Columbia, 2255 Wesbrook Mall, Vancouver, BC, V6T 1Z3, Canada
- 4Institute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai 200031, China
- 5PET center, Huashan Hospital, Fudan University, Shanghai 200040
- 6High Magnetic Field Laboratory, Hefei Institutes of Physical Science, Chinese Academy of Sciences& Neurodegenerative Disease Research Center, School of Life Sciences, University of Science and Technology of China, CAS Key Laboratory of Brain Functions and Disease, Anhui, China
- 7Advanced Innovation Center for Human Brain Protection, The National Clinical Research Center for Geriatric Disease, Xuanwu Hospital, Capital Medical University, Beijing, 100053, China
- 8Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas 77030, USA
- 9School of Life Sciences, Peking-Tsinghua Center for Life Sciences, and Peking University McGovern Institute, Peking University, Beijing 100871, China
- 10Department of Rehabilitation Medicine, Huashan Hospital, State Key Laboratory of Medical Neurobiology, Institute for Translational Brain Research, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China
- 11Oujiang Laboratory, Key Laboratory of Alzheimer’s Disease of Zhejiang Province, The Second Affiliated Hospital and Yuying Children’s Hospital, Institute of Aging, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
- ↵*Correspondence: zhongcj{at}163.com, weihong{at}mail.ubc.ca
↵† These authors contributed equally
Posted September 23, 2024.
Thiamine pyrophosphokinase-1 deficiency in neurons drives Alzheimer’s multiple pathophysiological alterations
